27623772|t|Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy.
27623772|a|BACKGROUND: Peripheral inflammation contributes to the neurological alterations in hepatic encephalopathy (HE). Neuroinflammation and altered GABAergic neurotransmission mediate cognitive and motor alterations in rats with HE. It remains unclear (a) if neuroinflammation and neurological impairment in HE are a consequence of peripheral inflammation and (b) how neuroinflammation impairs GABAergic neurotransmission. The aims were to assess in rats with HE whether reducing peripheral inflammation with anti-TNF-alpha (1) prevents cognitive impairment and motor in-coordination, (2) normalizes neuroinflammation and extracellular GABA in the cerebellum and also (3) advances the understanding of mechanisms linking neuroinflammation and increased extracellular GABA. METHODS: Rats with HE due to portacaval shunt (PCS) were treated with infliximab. Astrocytes and microglia activation and TNF-alpha and IL-1beta were analyzed by immunohistochemistry. Membrane expression of the GABA transporters GAT-3 and GAT-1 was analyzed by cross-linking with BS3. Extracellular GABA was analyzed by microdialysis. Motor coordination was tested using the beam walking and learning ability using the Y maze task. RESULTS: PCS rats show peripheral inflammation, activated astrocytes, and microglia and increased levels of TNF-alpha and IL-1beta. Membrane expression of GAT-3 and extracellular GABA are increased, leading to impaired motor coordination and learning ability. Infliximab reduces peripheral inflammation, microglia, and astrocyte activation and neuroinflammation and normalizes GABAergic neurotransmission, motor coordination, and learning ability. CONCLUSIONS: Neuroinflammation is associated with altered GABAergic neurotransmission and increased GAT-3 membrane expression and extracellular GABA (a); peripheral inflammation is a main contributor to the impairment of motor coordination and of the ability to learn the Y maze task in PCS rats (b); and reducing peripheral inflammation using safe procedures could be a new therapeutic approach to improve cognitive and motor function in patients with HE
27623772	0	10	Infliximab	Chemical	MESH:D000069285
27623772	30	42	inflammation	Disease	MESH:D007249
27623772	44	61	neuroinflammation	Disease	MESH:D000090862
27623772	81	85	GABA	Chemical	MESH:D005680
27623772	152	156	rats	Species	10116
27623772	162	184	hepatic encephalopathy	Disease	MESH:D006501
27623772	209	221	inflammation	Disease	MESH:D007249
27623772	241	265	neurological alterations	Disease	MESH:D009461
27623772	269	291	hepatic encephalopathy	Disease	MESH:D006501
27623772	293	295	HE	Disease	MESH:D006501
27623772	298	315	Neuroinflammation	Disease	MESH:D000090862
27623772	364	395	cognitive and motor alterations	Disease	MESH:D003072
27623772	399	403	rats	Species	10116
27623772	409	411	HE	Disease	MESH:D006501
27623772	439	456	neuroinflammation	Disease	MESH:D000090862
27623772	461	484	neurological impairment	Disease	MESH:D009422
27623772	488	490	HE	Disease	MESH:D006501
27623772	523	535	inflammation	Disease	MESH:D007249
27623772	548	565	neuroinflammation	Disease	MESH:D000090862
27623772	630	634	rats	Species	10116
27623772	640	642	HE	Disease	MESH:D006501
27623772	671	683	inflammation	Disease	MESH:D007249
27623772	694	703	TNF-alpha	Gene	24835
27623772	717	737	cognitive impairment	Disease	MESH:D003072
27623772	780	797	neuroinflammation	Disease	MESH:D000090862
27623772	816	820	GABA	Chemical	MESH:D005680
27623772	901	918	neuroinflammation	Disease	MESH:D000090862
27623772	947	951	GABA	Chemical	MESH:D005680
27623772	962	966	Rats	Species	10116
27623772	972	974	HE	Disease	MESH:D006501
27623772	1023	1033	infliximab	Chemical	MESH:D000069285
27623772	1075	1084	TNF-alpha	Gene	24835
27623772	1089	1097	IL-1beta	Gene	24494
27623772	1164	1168	GABA	Chemical	MESH:D005680
27623772	1182	1187	GAT-3	Gene	79213
27623772	1192	1197	GAT-1	Gene	79212
27623772	1233	1236	BS3	Chemical	MESH:C035760
27623772	1252	1256	GABA	Chemical	MESH:D005680
27623772	1398	1402	rats	Species	10116
27623772	1419	1431	inflammation	Disease	MESH:D007249
27623772	1493	1502	TNF-alpha	Gene	24835
27623772	1507	1515	IL-1beta	Gene	24494
27623772	1540	1545	GAT-3	Gene	79213
27623772	1564	1568	GABA	Chemical	MESH:D005680
27623772	1595	1622	impaired motor coordination	Disease	MESH:D001259
27623772	1645	1655	Infliximab	Chemical	MESH:D000069285
27623772	1675	1687	inflammation	Disease	MESH:D007249
27623772	1729	1746	neuroinflammation	Disease	MESH:D000090862
27623772	1846	1863	Neuroinflammation	Disease	MESH:D000090862
27623772	1933	1938	GAT-3	Gene	79213
27623772	1977	1981	GABA	Chemical	MESH:D005680
27623772	1998	2010	inflammation	Disease	MESH:D007249
27623772	2040	2072	impairment of motor coordination	Disease	MESH:D001259
27623772	2124	2128	rats	Species	10116
27623772	2158	2170	inflammation	Disease	MESH:D007249
27623772	2272	2280	patients	Species	9606
27623772	2286	2288	HE	Disease	MESH:D006501
27623772	Association	MESH:C035760	79213
27623772	Association	MESH:D005680	MESH:D000090862
27623772	Negative_Correlation	MESH:D000069285	MESH:D007249
27623772	Positive_Correlation	MESH:D005680	MESH:D001259
27623772	Association	MESH:D005680	79212
27623772	Association	MESH:D005680	79213
27623772	Negative_Correlation	MESH:D000069285	MESH:D000090862
27623772	Association	MESH:D007249	24835
27623772	Association	MESH:D001259	79213
27623772	Association	MESH:C035760	79212
27623772	Negative_Correlation	MESH:D000069285	MESH:D006501
27623772	Association	MESH:D000090862	79213
27623772	Negative_Correlation	MESH:D000069285	MESH:D005680
27623772	Positive_Correlation	MESH:D007249	24494

